Current Pharmacogenomics and Personalized Medicine
Title:Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?
Volume: 10 Issue: 3
Author(s): Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
Affiliation:
Keywords: Antipsychotic, Blood-brain-barrier, Dopamine receptor, Neuroimaging, P-glycoprotein, Pituitary.
Export Options
About this article
Cite this article as:
Reist Christopher, Mukherjee Jogeshwar and C. Wu Joseph, Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier?, Current Pharmacogenomics and Personalized Medicine 2012; 10 (3) . https://dx.doi.org/10.2174/187569212802509979
DOI https://dx.doi.org/10.2174/187569212802509979 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
Current Pharmaceutical Design Involvement of microRNA-146a in the Inflammatory Response of S tatus Epilepticus Rats
CNS & Neurological Disorders - Drug Targets Sedation in PACU: The Role of Propofol
Current Drug Targets Clustering Based Approach for Segmentation of Optic Cup and Optic Disc for Detection of Glaucoma
Current Medical Imaging A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases
Current Pharmaceutical Design Synthesis of Asymmetric 1-Thiocarbamoyl Pyrazoles as Potent Anti- Colon Cancer, Antioxidant and Anti-Inflammatory Agent
Anti-Cancer Agents in Medicinal Chemistry Targeting the Hedgehog Pathway: The development of Cyclopamine and the Development of Anti-Cancer Drugs Targeting the Hedgehog Pathway
Mini-Reviews in Medicinal Chemistry Dietary Factors in Childhood Obesity
Current Nutrition & Food Science Therapeutic Potential of Metabotropic GABA (GABAB) Receptors and their Effector Ion Channels
Central Nervous System Agents in Medicinal Chemistry How Do Parent-Child Interactions Predict and Maintain Depression in Childhood and Adolescence? A Critical Review of the Literature
Adolescent Psychiatry A Computational View of COX-2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Reviewing the Role of Donepezil in the Treatment of Alzheimer’s Disease
Current Alzheimer Research Nanoparticles in Melanoma
Current Medicinal Chemistry Oxidative Stress in the ICU
Current Nutrition & Food Science Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients
Protein & Peptide Letters Phage Display Derived Therapeutic Antibodies
Current Pharmaceutical Biotechnology Antioxidant to Treat Osteoarthritis: Dream or Reality?
Current Drug Targets Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Conference Report (11th International Conference on Neuroprotective Agents, Wendake, Quebec City, Quebec, Canada, Sept 30-Oct 3, 2012)
CNS & Neurological Disorders - Drug Targets The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets